Global Breast Imaging Devices Market Report 2022: Featuring Siemens, GE Healthcare, Fujifilm, Toshiba, Canon, Hologic & More


Dublin, March 06, 2023 (GLOBE NEWSWIRE) -- The "Global Breast Imaging Devices Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

The global breast imaging devices market is expected to grow from $4.06 billion in 2021 to $4.31 billion in 2022 at a compound annual growth rate (CAGR) of 6.3%. The market is expected to grow to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%.

North America was the largest region in the breast imaging devices market in 2021. Asia Pacific was the second largest market in breast imaging devices market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The rising prevalence of breast cancer is anticipated to contribute to the breast imaging devices market's growth. A growing number of hormone replacement therapy (HRT), hormonal imbalances, menopause, and various reproductive disorders have significantly increased the risks of breast cancer.

According to the World Health Organization (WHO), breast cancer is the most common cancer in women, impacting 2.1 million women annually. Breast cancer causes the highest number of cancer-related deaths among women. For instance, in 2020, according to the American Institute of cancer research, there were an estimated 18.1 million cancer cases around the world. It was estimated that 9.3 million cases were in men and 8.8 million in women. Among them, lung and breast cancers are the most common cancers in the world, and about 12.5% and 12.2% of the new cases are diagnosed in 2020.

The high cost associated with breast imaging devices is expected to limit the growth of the market shortly. The cost of digital mammography systems varies for different models and companies.

For instance, the cost of the 2D model's mammography systems ranges between $65,000 to $95,000 for GE Healthcare and Hologic, Inc products. Whereas 3D models of the same company range between $90,000 to $200,000. In addition to this, the premium 3D models of GE Healthcare and Hologic Inc. are priced between $1,40,000 to $2,75,000. Therefore, the high cost of breast imaging systems is a major concern for end-users, which is predicted to hinder the growth of the breast imaging devices market over the forecast period.

Major players operating in the breast imaging devices market are undertaking various strategic initiatives such as the launch of technologically advanced or innovative products and product portfolio expansion, which is likely to be a leading trend in the breast imaging market. Various companies are introducing new advanced devices in the market to attract a large customer base and maintain their position in the competitive business environment.

For instance, in March 2021, Siemens Healthineers, a company operating in breast imaging devices based in Germany launched a new software solution Mammovista B.smart that works on AI technology and boosts the breast image reading process, tracks, and analyses the workflow. It has features such as it reduces the loading time and helping the radiologist in reading the number of patient databases.

In June 2019, Hologic, Inc., a USA-based innovative medical technology company focused on improving women's health and well-being through early treatment and diagnosis, announced the acquisition of SuperSonic Imagine for an amount of $85 million.

With the acquisition of SuperSonic Imagine, Hologic, Inc. aims to gain entry into cart-based breast ultrasound technology used to screen women with dense breast tissue. SuperSonic Imagine is a France-based company specialized in ultrasound medical imaging including breast imaging devices.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Scope

Markets Covered:

1) By Product Type: Tomosynthesis; Breast Ultrasound; Breast MRI; Mammography; Nuclear Imaging; Other Product Types
2) By Technology: Ionizing; Non Ionizing
3) By End User: Hospitals & Clinics; Breast Care Centers; Diagnostic Imaging Centers

Report AttributeDetails
No. of Pages175
Forecast Period2022 - 2026
Estimated Market Value (USD) in 2022$4.31 billion
Forecasted Market Value (USD) by 2026$5.27 billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal



Key Topics Covered:

1. Executive Summary

2. Breast Imaging Devices Market Characteristics

3. Breast Imaging Devices Market Trends And Strategies

4. Impact Of COVID-19 On Breast Imaging Devices

5. Breast Imaging Devices Market Size And Growth

6. Breast Imaging Devices Market Segmentation

7. Breast Imaging Devices Market Regional And Country Analysis

8. Asia-Pacific Breast Imaging Devices Market

9. China Breast Imaging Devices Market

10. India Breast Imaging Devices Market

11. Japan Breast Imaging Devices Market

12. Australia Breast Imaging Devices Market

13. Indonesia Breast Imaging Devices Market

14. South Korea Breast Imaging Devices Market

15. Western Europe Breast Imaging Devices Market

16. UK Breast Imaging Devices Market

17. Germany Breast Imaging Devices Market

18. France Breast Imaging Devices Market

19. Eastern Europe Breast Imaging Devices Market

20. Russia Breast Imaging Devices Market

21. North America Breast Imaging Devices Market

22. USA Breast Imaging Devices Market

23. South America Breast Imaging Devices Market

24. Brazil Breast Imaging Devices Market

25. Middle East Breast Imaging Devices Market

26. Africa Breast Imaging Devices Market

27. Breast Imaging Devices Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Breast Imaging Devices Market

29. Breast Imaging Devices Market Future Outlook and Potential Analysis

30. Appendix

A selection of companies mentioned in this report includes

  • Siemens Healthcare
  • GE Healthcare
  • Dilon Technologies Inc.
  • Hologic inc.
  • Gamma Medica inc.
  • Fujifilm Holdings Corporation
  • SonoCine inc.
  • Philips Healthcare
  • Toshiba Corporation
  • Aurora Imaging Technology Inc.
  • Canon Inc.
  • Dilon Technologies inc.
  • Delphinus Medical Technologies
  • Planmed Oy
  • Micrima Limited
  • CMR Naviscan Corporation
  • SuperSonic Imagine
  • Carestream Health
  • Samsung Medison Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/ng8ojd

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Breast Imaging Devices Market

Coordonnées